Zobrazeno 1 - 1
of 1
pro vyhledávání: '"V Shrinvastava"'
Autor:
Suhail M. Ali, Syed Rizvi, R Kalu, V Shrinvastava, A. Lipton, K Repich, Matt Evans, Sheryl Brown-Shimer, Peter J. Hamer, E-M Fuchs, U. Anyanwu, Kim Leitzel, Jessica Ramirez, W. Koestler, H. Y. Hou, Walter P. Carney
Publikováno v:
Cancer Research. 70:P2-09
Background: Approximately one-half of HER2-positive breast cancer patients will respond to first-line trastuzumab-containing therapy. However, in those patients with an initial trastuzumab response, most will progress within a year with acquired resi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::060e5a5e28171de19fe107f9eed4fc0e
https://doi.org/10.1158/0008-5472.sabcs10-p2-09-07
https://doi.org/10.1158/0008-5472.sabcs10-p2-09-07
